InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,277.51
(
0.80%
)
US TECH 100
18,028.40
(
0.00%
)
Dow Jones
38,686.32
(
1.51%
)
Brent Oil
81.11
(
0.37%
)
Bitcoin
68,844.05
(
1.62%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

greggors

Send PM Follow Ignore
Followers 14
Posts 968
Boards Moderated 0
Alias Born 04/27/2012

greggors

Re: None

Friday, 06/17/2016 1:24:58 PM

Friday, June 17, 2016 1:24:58 PM

Post# of 80490
Quote....
"A decision to build upon the Company’s core strengths in precision small molecule therapies and rare cancers, including investing in potential new opportunities in immuno-oncology, with pharmacologic proof-of-concept achieved against a validated lead target."

Immuno-oncology? ARIAD? Hmm
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up